CUSIP Y95308105 · who reports it, how much, and how much it matters to them
30 of the 720 hedge fund managers we track reported shares of Wave Life Sciences, Inc. (Nasdaq: WVE) on Form 13F for 30 June 2026. Between them they reported USD 389m. The largest position belongs to Ra Capital Management, at USD 157m. The manager with the most riding on it is M28 Capital Management, where it is 56.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 157m | 1.4% |
| 2 | Maverick Capital20 funds on PPLI.com | USD 60m | 0.5% |
| 3 | 683 Capital Management2 funds on PPLI.com | USD 29m | 1.4% |
| 4 | M28 Capital Management1 fund on PPLI.com | USD 27m | 56.5% |
| 5 | Two Sigma Investments35 funds on PPLI.com | USD 22m | 0.0% |
| 6 | Squarepoint Ops7 funds on PPLI.com | USD 15m | 0.0% |
| 7 | Millennium Management6 funds on PPLI.com | USD 11m | 0.0% |
| 8 | D. E. Shaw & Co.15 funds on PPLI.com | USD 10m | 0.0% |
| 9 | Renaissance Technologies13 funds on PPLI.com | USD 9.9m | 0.0% |
| 10 | POINT72 Asset Management17 funds on PPLI.com | USD 8.6m | 0.0% |
| 11 | RTW Investments2 funds on PPLI.com | USD 7.8m | 0.1% |
| 12 | Marshall Wace LLP84 funds on PPLI.com | USD 5.8m | 0.0% |
| 13 | Baker Bros. Advisors2 funds on PPLI.com | USD 4.8m | 0.0% |
| 14 | Capital Fund Management S.A.12 funds on PPLI.com | USD 4.3m | 0.0% |
| 15 | Sphera Funds Management1 fund on PPLI.com | USD 3.7m | 0.5% |
| 16 | Walleye Capital8 funds on PPLI.com | USD 3.4m | 0.0% |
| 17 | Citadel Advisors32 funds on PPLI.com | USD 2.8m | 0.0% |
| 18 | Platinum Investment Management11 funds on PPLI.com | USD 1.6m | 0.4% |
| 19 | Exoduspoint Capital Management7 funds on PPLI.com | USD 1.5m | 0.0% |
| 20 | Newtyn Management3 funds on PPLI.com | USD 1.2m | 0.2% |
| 21 | Sofinnova Investments1 fund on PPLI.com | USD 1.1m | 0.1% |
| 22 | Burkehill Global Management5 funds on PPLI.com | USD 872,000 | 0.0% |
| 23 | Boothbay Fund Management2 funds on PPLI.com | USD 842,000 | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 407,000 | 0.0% |
| 25 | Brevan Howard Capital Management39 funds on PPLI.com | USD 354,000 | 0.0% |
| 26 | Engineers Gate Manager1 fund on PPLI.com | USD 296,000 | 0.0% |
| 27 | Bayforest Capital1 fund on PPLI.com | USD 284,000 | 0.3% |
| 28 | Verition Fund Management3 funds on PPLI.com | USD 232,000 | 0.0% |
| 29 | Mirabella Financial Services LLP10 funds on PPLI.com | USD 140,000 | 0.0% |
| 30 | Graham Capital Management18 funds on PPLI.com | USD 125,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | M28 Capital Management | USD 27m | 56.5% |
| 2 | 683 Capital Management | USD 29m | 1.4% |
| 3 | Ra Capital Management | USD 157m | 1.4% |
| 4 | Maverick Capital | USD 60m | 0.5% |
| 5 | Sphera Funds Management | USD 3.7m | 0.5% |
| 6 | Platinum Investment Management | USD 1.6m | 0.4% |
| 7 | Bayforest Capital | USD 284,000 | 0.3% |
| 8 | Newtyn Management | USD 1.2m | 0.2% |
| 9 | RTW Investments | USD 7.8m | 0.1% |
| 10 | Sofinnova Investments | USD 1.1m | 0.1% |
Wave Life Sciences, Inc. trades under the symbol WVE on the Nasdaq. Its CUSIP, the code used on Form 13F, is Y95308105.
30 of the 720 hedge fund managers PPLI.com tracks reported Wave Life Sciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 157m), Maverick Capital (USD 60m), 683 Capital Management (USD 29m), M28 Capital Management (USD 27m) and Two Sigma Investments (USD 22m).
30 managers in our coverage reported it, and between them they run 360 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
M28 Capital Management, where the position was 56.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Wave Life Sciences, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.